On the Hot Seat: An Immersive Course for Optimizing PET Imaging in Early Alzheimer’s Disease
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …